Precision molecular pathology of prostate cancer. (2018)
- Record Type:
- Book
- Title:
- Precision molecular pathology of prostate cancer. (2018)
- Main Title:
- Precision molecular pathology of prostate cancer
- Further Information:
- Note: Brian D. Robinson, Juan Miguel Mosquera, Jae Y. Ro, Mukul Divatia, editors.
- Editors:
- Robinson, Brian D
Mosquera, Juan Miguel
Ro, Jae Y
Divatia, Mukul - Contents:
- Intro; Contents; Editors and Contributors; Part I: General Principles; Chapter 1: Precision Medicine in Prostate Cancer: Approach to the Patient; Introduction; Precision Medicine in Prostate Cancer; Newly Diagnosed Prostate Cancer; Advanced Prostate Cancer; Initial Clinical Encounter; Family History in Prostate Disease; Informed Consent; Patient Preferences and Data Privacy; Actionability of Precision Medicine Results; Turnaround Time; Tissue for Genomic Profiling and Need for Serial Biopsies; Understanding â#x80;#x9C;Precision Medicine Reportsâ#x80;#x9D. Communicating Genomic Information to Clinicians and PatientsUnique Issues Related to Incidental Discovery of Germline Mutations; Future Direction; Resources for Patients and Clinicians; References; Chapter 2: Epidemiology and Etiology; Introduction: Incidence and Mortality; Etiology and Risk Factors; Modifiable; Age; Family History and Genetic Alterations (Inherited and Acquired); Race and Ethnicity; Modifiable; Obesity, Exercise, Diet, and Diabetes (Metabolic); Smoking; Conclusions; References; Chapter 3: High-Grade Prostatic Intraepithelial Neoplasia. Definition, Incidence and Evidence of Preneoplastic ProcessMolecular Features of HGPIN; Telomere Shortening; Cytogenetic Alterations; Overexpression of p16; c-myc Amplification and Caveolin-1 Overexpression; Dysregulation of Annexin; Glutathione-S-Transferase Gene Methylation; Mammalian Target of Rapamycin (mTOR) Pathway; MicroRNA ExpressionIntro; Contents; Editors and Contributors; Part I: General Principles; Chapter 1: Precision Medicine in Prostate Cancer: Approach to the Patient; Introduction; Precision Medicine in Prostate Cancer; Newly Diagnosed Prostate Cancer; Advanced Prostate Cancer; Initial Clinical Encounter; Family History in Prostate Disease; Informed Consent; Patient Preferences and Data Privacy; Actionability of Precision Medicine Results; Turnaround Time; Tissue for Genomic Profiling and Need for Serial Biopsies; Understanding â#x80;#x9C;Precision Medicine Reportsâ#x80;#x9D. Communicating Genomic Information to Clinicians and PatientsUnique Issues Related to Incidental Discovery of Germline Mutations; Future Direction; Resources for Patients and Clinicians; References; Chapter 2: Epidemiology and Etiology; Introduction: Incidence and Mortality; Etiology and Risk Factors; Modifiable; Age; Family History and Genetic Alterations (Inherited and Acquired); Race and Ethnicity; Modifiable; Obesity, Exercise, Diet, and Diabetes (Metabolic); Smoking; Conclusions; References; Chapter 3: High-Grade Prostatic Intraepithelial Neoplasia. Definition, Incidence and Evidence of Preneoplastic ProcessMolecular Features of HGPIN; Telomere Shortening; Cytogenetic Alterations; Overexpression of p16; c-myc Amplification and Caveolin-1 Overexpression; Dysregulation of Annexin; Glutathione-S-Transferase Gene Methylation; Mammalian Target of Rapamycin (mTOR) Pathway; MicroRNA Expression Profiles; TMPRSS2-ERG Fusion; Clinical Significance of HGPIN; References; Chapter 4: Pathology of Prostate Cancer; Introduction; Diagnosis of Prostatic Adenocarcinoma; Abnormal Architecture or Pattern of Glands; Loss of Basal Cell Layer. Nuclear AtypiaMinor Criteria That Are Helpfulâ#x80;#x94;But Not Requiredâ#x80;#x94;In the Diagnosis of Prostatic Adenocarcinoma; Intraluminal Blue-Tinged Mucin; Amorphous Pink Secretions; Crystalloids; Cytoplasmic Changes; Grading of Prostatic Adenocarcinoma; Variants of Acinar Adenocarcinoma; Variants of Non-acinar Carcinoma; Immunohistochemistry; Treatment Effect; Special Issues Related to Biopsy, TURP, and Prostatectomy Specimens; Needle Core Biopsy; Transurethral Resection of Prostate (TURP); Radical Prostatectomy; Conclusion; References; Chapter 5: Genetic Susceptibility; Introduction. Hereditary Prostate CancerBRCA1 and BRCA2 Genes; BRCA Genes and Cancer Risk; BRCA and Tumourigenesis; Poly(ADP-ribose) Polymerase 1 (PARP1); Susceptibility Genes; Androgen Receptor (AR) Gene; RNASEL Gene; TMPRSS2-ERG Gene Fusion; HOXB13; Mismatch Repair (MMR) Genes and Prostate Cancer; Lynch Syndrome; MSH2; Fanconi Anaemia; The FA Pathway; FA Genes and Prostate Cancer; DNA Adducts; Conclusion; References; Chapter 6: Racial Differences; Differences in the Epidemiology of Prostate Cancer Among Ethnicities; Incidence and Mortality Across Ethnic Populations Within the United States. … (more)
- Publisher Details:
- Cham, Switzerland : Springer
- Publication Date:
- 2018
- Extent:
- 1 online resource
- Subjects:
- 616.99/4630758
Medicine
Prostate -- Cancer -- Molecular diagnosis
HEALTH & FITNESS -- Diseases -- General
MEDICAL -- Clinical Medicine
MEDICAL -- Diseases
MEDICAL -- Evidence-Based Medicine
MEDICAL -- Internal Medicine
Prostate -- Cancer -- Molecular diagnosis
Medical -- Oncology
Medical -- Urology
Oncology
Urology & urogenital medicine
Pathology
Oncology
Urology
Medical -- Pathology
Pathology
Electronic books - Languages:
- English
- ISBNs:
- 9783319640969
3319640968 - Related ISBNs:
- 9783319640945
3319640941 - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.366031
- Ingest File:
- 01_340.xml